Policy opportunities to increase HPV vaccination in rural communities

Robin C Vanderpool, Lindsay R Stradtman, Heather M Brandt, Robin C Vanderpool, Lindsay R Stradtman, Heather M Brandt

Abstract

Rural communities experience health disparities, including elevated incidence and mortality of human papillomavirus (HPV)-associated cancers and correspondingly low HPV vaccination rates. There are numerous policy strategies that are available at multiple levels - patient, provider, clinic, community, state, and national - to address geographic, clinical, and communication barriers to HPV vaccination across rural America. Examples include policy development, implementation, and evaluation of healthcare provider and clinic-based assessment and education initiatives; school entry requirements; school, pharmacy, and community-based vaccination programs; evidence-based, community-driven communication efforts; and increased interventional research in rural communities. Strategically implemented policy measures will contribute to reduction in the incidence and mortality from HPV-related cancers through increased access to HPV vaccination in our rural communities.

Keywords: Cancer prevention; HPV vaccination; public health policy; rural; vaccination.

References

    1. Markowitz L, Gee J, Chesson H, Stokley S.. Ten years of Human Papillomavirus vaccination in the United States. Acad Pediatr. 2018;18(2s):S3–S10. doi:10.1016/j.acap.2017.09.014.
    1. Osazuwu-Peters N. Human papillomavirus (HPV), HPV-associated oropharyngeal cancer, and HPV vaccine in the United States–do we need a broader vaccine policy? Vaccine. 2013;31(47):5500–5505. doi:10.1016/j.vaccine.2013.09.031.
    1. Meites E, Kempe A, Markowitz L. Use of a 2-dose schedule for Human Papillomavirus vaccination - Updated recommendations of the Advisory Committee on Immunization Practices. MMWR. 2016;65(49):1405–1408. doi:10.15585/mmwr.mm6549a5.
    1. U.S Food & Drug Administration FDA approves expanded use of Gardasil 9 to include individuals 27 through 45 years old. Silver Spring (MD): U.S. Food & Drug Administration; 2018 October5 [accessed 2018 Oct 8]. .
    1. Walker T, Elam-Evans L, Yankey D, Markowitz L, Williams C, Mbaeyi S, Fredua B, Stokley S. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 Years — United States, 2017. MMWR. 2018;67(33):909–917. doi:10.15585/mmwr.mm6733a1.
    1. Zahnd W, James A, Jenkins W, Izadi S, Fogleman A, Steward D, Colditz G, Brard L. Rural–Urban differences in cancer incidence and trends in the United States. Cancer Epidemiol Biomarkers Prev. 2018;27(11):1265–1274. doi:10.1158/1055-9965.EPI-17-0430.
    1. Ware S, Crosby R, Fisher R, Hagensee M. Human papillomavirus prevalence is associated with socioeconomic gradients within a medically underserved Appalachian region. Sex Transm Dis. 2017;44(12):750–755. doi:10.1097/OLQ.0000000000000675.
    1. Vielot N, Butler A, Brookhart M, Becker-Dreps S, Smith J. Patterns of use of human papillomavirus and other adolescent vaccines in the United States. J Adolesc Health. 2017;61(3):281–287. doi:10.1016/j.jadohealth.2017.05.016.
    1. President’s Cancer Panel HPV vaccination for cancer prevention: progress, opportunities, and a renewed call to action. A report to the president of the United States from the chair of the President’s Cancer Panel. Bethesda (MD): U.S. Department of Health and Human Services, 2018.
    1. U.S. Cancer Statistics Working Group U.S. cancer statistics data visualizations tool, based on November 2017 submission data (1999–2015). Atlanta (GA): U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2018 June [accessed 2018 Oct 8]. .
    1. Paskett E, Krok-Schoen J, Pennell M, Tatum C, Reiter P, Peng J, Bernardo B, Weier R, Richardson M, Katz M. Results of a multilevel intervention trial to increase human papillomavirus (HPV) vaccine uptake among adolescent girls. Cancer Epidemiol Biomarkers Prev. 2016;25(4):593–602. doi:10.1158/1055-9965.
    1. Boyd E, Phillips J, Schoenberger Y, Simpson T. Barriers and facilitators to HPV vaccination among rural Alabama adolescents and their caregivers. Vaccine. 2018;36(28):4126–4133. doi:10.1016/j.vaccine.2018.04.085.
    1. Moss J, Gilkey M, Rimer B, Brewer N. Disparities in collaborative patient-provider communication about human papillomavirus (HPV) vaccination. Hum Vaccin Immunother. 2016;12(6):1476–1483. doi:10.1080/21645515.2015.1128601.
    1. Mohammed K, Subramaniam D, Geneus C, Henderson E, Dean C, Subramaniam D, Burroughs TE. Rural-urban differences in human papillomavirus knowledge and awareness among US adults. Prev Med. 2018;109:39–43. doi:10.1016/j.ypmed.2018.01.016.
    1. Blake K, Ottenbacher A, Finney Rutten L, Grady M, Kobrin S, Jacobson R, Hesse B. Predictors of human papillomavirus awareness and knowledge in 2013: gaps and opportunities for targeted communication strategies. Am J Prev Med. 2015;48(4):402–410. doi:10.1016/j.amepre.2014.10.024.
    1. Dilley S, Peral S, Straughn J Jr., Scarinci I. The challenge of HPV vaccination uptake and opportunities for solutions: lessons learned from Alabama. Prev Med. 2018;113:124–131. doi:10.1016/j.ypmed.2018.05.021.
    1. Vanderpool R, Dressler E, Stradtman L, Crosby R. Fatalistic beliefs and completion of the HPV vaccination series among a sample of young Appalachian Kentucky women. J Rural Health. 2015;31(2):199–205. doi:10.1111/jrh.12102.
    1. National Cancer Institute Intervention programs: HPV vaccination. Research-tested intervention programs. Bethesda (MD): National Cancer Institute; [accessed 2018. October 10]. .
    1. Brownson R, Chriqui J, Stamatakis K. Understanding evidence-based public health policy. Am J Public Health. 2009;99(9):1576–1583. doi:10.2105/AJPH.2008.156224.
    1. U.S. Department of Health and Human Services Accelerating HPV vaccine uptake: urgency for action to prevent cancer. A Report to the President of the United States from the President’s Cancer Panel. Bethesda (MD): National Cancer Institute; 2014.
    1. Rural Health Information Hub RHIhub maps on rural health workforce. Grand Forks (ND): Rural Health Information hub; [accessed 2018 Oct 8]. .
    1. Shipman S, Lan J, Chang C, Goodman D. Geographic maldistribution of primary care for children. Pediatrics. 2011;127(1):19–27. doi:10.1542/peds.2010-0150.
    1. Centers for Disease Control and Prevention Rural health: vaccination in rural communities. Atlanta (GA): Centers for Disease Control and Prevention; 2018 October3 [accessed 2018 Oct 8]. .
    1. Kepka D, Spigarelli M, Warner E, Yoneoka Y, McConnell N, Balch A. Statewide analysis of missed opportunities for human papillomavirus vaccination using vaccine registry data. Papillomavirus Res. 2016;2:128–132. doi:10.1016/j.pvr.2016.06.002.
    1. Samara P, Zimet G, Tatar O, Stupiansky N, Fisher W, Rosberger Z. Human apillomavirus vaccines: successes and future challenges. Drugs. 2018;78(14):1385–1396. doi:10.1007/s40265-018-0975-6.
    1. Ruffin M 4th, Plegue M, Rockwell P, Young A, Patel D, Yeazel MW. Impact of an electronic health record (EHR) reminder on human papillomavirus (HPV) vaccine initiation and timely completion. J Am Board Fam Med. 2015;28(3):324–333. doi:10.3122/jabfm.2015.03.140082.
    1. Kasting M, Christy S, Sutton S, Lake P, Malo T, Roetzheim R, Schechtman T, Zimet G, Walkosz B, Salmon D, et al. Florida physicians’ reported use of AFIX-based strategies for human papillomavirus vaccination. Prev Med. 2018;116:143–149. doi:10.1016/j.ypmed.2018.09.004.
    1. Centers for Disease Control and Prevention Vaccines for Children (VCF) program. Atlanta (GA): Centers for Disease Control and Prevention; 2018 April16 [accessed 2018 Oct 8]. .
    1. LeBaron C, Lyons B, Massoudi M, Stevenson J. Childhood vaccination providers in the United States. Am J Public Health. 2002;92(2):266–270.
    1. Rural Health Information Hub Rural pharmacy and prescription drugs. Grand Forks (ND): Rural Health Information Hub; 2018 October10 [accessed 2018 Oct 10].
    1. Vanderpool R, Pilar M, Barker J, Freeman P. Increasing HPV vaccination through community pharmacy partnerships: lessons learned from a pilot project. Frankfort, KY: The Kentucky Pharmacist; 2017. Jul-Aug p. 33–36.
    1. Dingman D, Schmit C. Authority of pharmacists to administer human papillomavirus vaccine: alignment of state laws with age-level recommendations. Public Health Rep. 2018;133(1):55–63. doi:10.1177/0033354917742117.
    1. Walling E, Benzoni N, Dornfeld J, Bhandari R, Sisk B, Garbutt J, Colditz G. Interventions to improve HPV vaccine uptake: A systematic review. Pediatrics. 2016;138(1):1–11. doi:10.1542/peds.2015-3863.
    1. McClure C, MacSwain M, Morrison H, Sanford C. Human papillomavirus vaccine uptake in boys and girls in a school-based vaccine delivery program in Prince Edward Island, Canada. Vaccine. 2015;33(15):1786–1790. doi:10.1016/j.vaccine.2015.02.047.
    1. Vanderpool R, Breheny P, Tiller P, Huckelby C, Edwards A, Upchurch K, Phillips C, Weyman C. Implementation and evaluation of a school-based human papillomavirus vaccination program in rural Kentucky. Am J Prev Med. 2015;49(2):317–323. doi:10.1016/j.amepre.2015.05.001.
    1. Pastir J. NCCDPHP success story: school HPV immunization clinics increase vaccination rates in North Dakota. Atlanta (GA): Centers for Disease Control and Prevention; [accessed 2018. October 8]. .
    1. Kempe A, Allison M, Daley M. Can school-located vaccination have a major impact on human papillomavirus vaccination rates in the United States? Acad Pediatr. 2018;18(2):S101–105. doi:10.1016/j.acap.2017.08.010.
    1. National Conference of State Legislators HPV vaccine: state legislation and statutes. Washington (DC): National Conference of State Legislators; [accessed 2018. November 1]. .
    1. Thompson E, Livingston M 3rd, Daley E, Zimet G. Human papillomavirus vaccine initiation for adolescents following Rhode Island’s school-entry requirement, 2010–2016. Am J Public Health. 2018;108(10):1421–1423. doi:10.2105/AJPH.2018.304552.
    1. Minter J. Improving HPV immunization rates: A mobile health approach; 2016 June17 [accessed 2018 Oct 8]. .
    1. Arnell T, Donnelly M, Nadeau A, Till L, York C, Zargari P, Howard A, Davis W, Finley C. Role of the dental community in HPV vaccination promotion; 2018. [accessed 2018 October 8]. .
    1. American Dental Association Council on Scientific Affairs Statement on human papillomavirus and squamous cell cancers of the oropharynx. Chicago (IL): American Dental Association; 2012 November [accessed 2018 Oct 8]. .
    1. Abiola S, Colgrove J, Mello M. The politics of HPV vaccination policy formation in the United States. J Health Polit Policy Law. 2013;38(4):645–681. doi:10.1215/03616878-2208567.
    1. Casper M, Carpenter L. Sex, drugs, and politics: the HPV vaccine for cervical cancer. Sociol Health Illn. 2008;30(6):886–899. doi:10.1111/j.1467-9566.2008.01100.x.
    1. National AHEC Organization HPV immunization project. Oak Creek (WI): National AHEC Organization; [accessed 2018. October 8]. .
    1. Blake K, Moss J, Gaysynsky A, Srinivasan S, Croyle R. Making the case for investment in rural cancer control: an analysis of rural cancer incidence, mortality, and funding trends. Cancer Epidemiol Biomarkers Prev. 2017;26(7):992–997. doi:10.1158/1055-9965.EPI-17-0092.
    1. Implementation Science Working Group Accelerating implementation of evidence-based cancer prevention and screening strategies. Bethesda (MD): National Cancer Institute; [accessed 2018. October 10]. .
    1. Kennedy A, Vanderpool R, Croyle R, Srinivasan S. An overview of the National Cancer Institute’s initiatives to accelerate rural cancer control research. Cancer Epidemiol Biomarkers Prev. 2018;27(11):1240–1244. doi:10.1158/1055-9965.EPI-18-0934.
    1. National Cancer Institute HPV vaccine uptake in cancer centers. Bethesda (MD): National Cancer Institute; 2018 September14 [accessed 2018Oct 8]. .

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner